does glp 1 help with inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Anti-Inflammatory Effects of GLP-1-Based Therapies

As rigorous studies begin to clarify mechanism, dose, timing, and patient selection, GLP-1 agents may one day play a supportive, targeted role for a specific subset of patients

In the long term, oral GLP-1s may be an early signal of how high-value therapies are manufactured in the future not purely based on cost, but where supply can be delivered most reliably

doi: 10.2337/dc21-S009

Both contain tirzepatide

A 2026 analysis in eClinicalMedicine , part of The Lancet family of journals, found that patients regained about 60% of the weight they lost within the first year after stopping GLP-1 therapy

A meta-analysis of 48 trials involving 27,729 participants found that 21.49% experienced nausea, while 9.10% reported vomiting